Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) , and
immune responses. A significant impediment to enhancing the efficacy of brain tumor treatment lies
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) /MEK/ERK pathway inhibitors, IDH mutation inhibitors,
immune checkpoint inhibitors, and CAR-
T cell therapies